200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 251-97-8
251-97-8 | Imidazo[2,1-b]thiazole
CAS No: 251-97-8 Catalog No: AG002QHC MDL No:MFCD01924763
Product Description
Catalog Number:
AG002QHC
Chemical Name:
Imidazo[2,1-b]thiazole
CAS Number:
251-97-8
Molecular Formula:
C5H4N2S
Molecular Weight:
124.1637
MDL Number:
MFCD01924763
IUPAC Name:
imidazo[2,1-b][1,3]thiazole
InChI:
InChI=1S/C5H4N2S/c1-2-7-3-4-8-5(7)6-1/h1-4H
InChI Key:
UFBBWLWUIISIPW-UHFFFAOYSA-N
SMILES:
c1nc2n(c1)ccs2
Properties
Complexity:
96.4
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
124.01g/mol
Formal Charge:
0
Heavy Atom Count:
8
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
124.161g/mol
Monoisotopic Mass:
124.01g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
45.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.9
Literature
| Title | Journal |
|---|---|
| Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives. | Molecules (Basel, Switzerland) 20120423 |
| Novel levamisole derivative induces extrinsic pathway of apoptosis in cancer cells and inhibits tumor progression in mice. | PloS one 20120101 |
| The fluorescence spectroscopic study on the interaction between imidazo[2,1-b]thiazole analogues and bovine serum albumin. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111201 |
| New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies. | European journal of medicinal chemistry 20111201 |
| 6-Fluoro-2-(4-meth-oxy-phen-yl)imidazo[2,1-b][1,3]benzothia-zole. | Acta crystallographica. Section E, Structure reports online 20111201 |
| Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents. | European journal of medicinal chemistry 20110601 |
| Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis. | Investigational new drugs 20110201 |
| TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents. | European journal of medicinal chemistry 20100201 |
| Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. | European journal of medicinal chemistry 20100101 |
| [6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity. | ChemMedChem 20091201 |
| Synthesis and evaluation of imidazo[2,1-b]thiazoles as iodide efflux inhibitors in thyrocytes. | ChemMedChem 20091101 |
| Synthesis and antiviral activity of azoles obtained from carbohydrates. | Carbohydrate research 20080922 |
| Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity. | Journal of medicinal chemistry 20080327 |
| Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors. | European journal of medicinal chemistry 20080301 |
| Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. | European journal of medicinal chemistry 20070301 |
| Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2,1-b]thiazole derivatives. | European journal of medicinal chemistry 20051201 |
| Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of imidazo[2,1-b]thiazole. | Arzneimittel-Forschung 20020101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.